| Teresa Marie Gilbride Trufant, MD | |
|
100 Brewster Blvd, Camp Lejeune, NC 28547-2575 | |
| (910) 450-4025 | |
| Not Available |
| Full Name | Teresa Marie Gilbride Trufant |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 100 Brewster Blvd, Camp Lejeune, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033569207 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101265853 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Teresa Marie Gilbride Trufant, MD 100 Brewster Blvd, Camp Lejeune, NC 28547-2575 Ph: (910) 450-4025 | Teresa Marie Gilbride Trufant, MD 100 Brewster Blvd, Camp Lejeune, NC 28547-2575 Ph: (910) 450-4025 |
News Archive
A nanoscopic beacon used by Melbourne researchers will help to enhance the design of smart gene and drug delivery systems.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
In order to kill, bladder cancer must metastasize, most commonly to the lung - what are the differences between bladder cancers that do and do not make this deadly transition? Research presented by the Director of the University of Colorado Cancer Center at the AACR Annual Meeting 2013 shows that one big difference is a little molecule known as hsa-miR-146a.
One-year survival was similar for adults with severe heart failure who received a heart transplant from a donor with hepatitis C compared to those who received hearts from donors who did not have hepatitis C, according to new research published today in the Journal of the American Heart Association, the open access journal of the American Heart Association.
INVO Bioscience announced that CECOLFES (http://cecolfes.com/), Colombia Fertility Center, Bogota, Colombia, the first center in Latin America to introduce the INVOcell device and the INVO procedure for treatment of infertility, made known today the results of the first 28 cycles of the INVO procedure.
› Verified 6 days ago
Dr. Mena A Shaker, MD, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Department Of Obstetrics And Gynecology, Camp Lejeune, NC 28547 Phone: 814-244-0789 | |
Joshua Monson, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-449-2750 | |
Dr. Steven Reid Banks, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547 Phone: 910-450-4159 Fax: 910-450-4194 | |
Dr. Jennifer Megan Fticsar, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-450-4566 | |
Dr. Abigail Marie Ramseyer, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547 Phone: 910-450-3905 Fax: 910-450-4558 | |
Dr. Elyse Marie Pertot, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Naval Medical Center, 100 Brewster Blvd., Camp Lejeune, NC 28547 Phone: 910-450-3434 |